Illustration: Gabriella Turrisi/Axios
Clarify Health, a VC-backed health data analytics company, has paused its Barclays-run sale process, Axios Pro has learned.
Why it matters: Clarify's cap-ex spend and EBITDA losses mean that it'll likely need some kind of lifeline eventually.
